Primary Care, Guidance

Applied filters

Care Setting (38)
- Care homes (7)
- Community Health Services (2)
- Dentistry (1)
- Paediatrics (1)
- Palliative and End of Life Care (1)
- Primary Care (38)
- Transfer of care (2)
Events (5)
- Past Events (5)
Guidance (38)
- Adherence (6)
- Administering (3)
- Adverse effects (2)
- Cautions and contraindications (1)
- Complementary medicines (1)
- Deprescribing (1)
- Formulation (1)
- Interactions (1)
- Medication Safety (3)
- Patient Group Directions (2)
- Pharmacogenomics (1)
- Poisoning (1)
- Policy, Commissioning and Managerial (1)
- Polypharmacy (4)
- Prescribing (2)
- Safety in Breastfeeding (1)
- Safety in Pregnancy (1)
- Service advice and planning (1)
- Swallowing difficulties (9)
- Switching (3)
- Unlicensed medicines (1)
Medicine (6)
- Adrenaline (1)
- Agomelatine (1)
- Amantadine (1)
- Amitriptyline (1)
- Beclometasone (1)
- Beclometasone + Formoterol (1)
- Bromocriptine (1)
- Budesonide (1)
- Budesonide + Formoterol (1)
- Buprenorphine (1)
- Cabergoline (1)
- Carbamazepine (1)
- Carbidopa + Levodopa + Entacapone (1)
- Ciclosporin (1)
- Citalopram (1)
- Clozapine (1)
- Co-beneldopa (1)
- Co-careldopa (1)
- Diltiazem (1)
- Doxazosin (1)
- Doxepin (1)
- Duloxetine (1)
- Entacapone (1)
- Escitalopram (1)
- Fentanyl (1)
- Fluoxetine (1)
- Fluticasone (1)
- Fluticasone + Formoterol (1)
- Fluticasone + Salmeterol (1)
- Fluvoxamine (1)
- Imipramine (1)
- Isocarboxazid (1)
- Levodopa + Carbidopa + Entacapone (1)
- Levothyroxine (1)
- Lithium (1)
- Lithium carbonate (1)
- Lofepramine (1)
- Mesalazine (1)
- Methylphenidate (1)
- Mianserin (1)
- Mirtazapine (1)
- Moclobemide (1)
- Morphine (1)
- Mycophenolate mofetil (1)
- Nifedipine (1)
- Nortriptyline (1)
- Oxycodone (1)
- Paroxetine (1)
- Pergolide (1)
- Phenelzine (1)
- Phenobarbital (1)
- Phenytoin (1)
- Pramipexole (1)
- Primidone (1)
- Rasagiline (1)
- Reboxetine (1)
- Ropinirole (1)
- Rotigotine (1)
- Selegiline (2)
- Sertraline (1)
- Tacrolimus (1)
- Tiotropium (1)
- Tolcapone (1)
- Tramadol (1)
- Tranylcypromine (1)
- Trimipramine (1)
- Venlafaxine (1)
- Vortioxetine (1)
Specialty (4)
- Cardiovascular system disorders (1)
- Endocrine system disorders (1)
- Mental health and illness (2)
  - Depression and anxiety (1)
- Neurological disorders (1)
Training and Development (13)

Five moments to tackle problematic polypharmacy podcasts

10 December 2025In these podcasts we discuss 5 moments to tackle problematic polypharmacy, using examples from community pharmacy practice and expert advice.

Polypharmacy and structured medication review explainer videos

31 October 2025These animated videos explain the 7 steps of structured medication review, using a person-centred approach to managing polypharmacy

MSATS – Safe use of medicines in palliative and end of life care

24 September 2025Discussion of medication safety challenges within palliative and end of life care; inspiring partnership across the system.

Parkinson’s disease medicines in swallowing difficulties

4 September 2025Guidance to help you ensure your patients with Parkinson’s Disease are able to get the most from their medicines if they develop swallowing difficulties

Information resources for advice about medicines in pregnancy

15 July 2025SPS and other resources can help pharmacy and other healthcare professionals provide advice on medicines in pregnancy.

Pharmacy First podcast series

19 June 2025Pharmacy colleagues and expert clinicians talk about issues surrounding the new service in community pharmacy and try to debunk some of the clinical myths.

MSATS - Safe Use of DOACs

30 October 2024Discussion of key current medication safety challenges within healthcare with a focus on the safe use of DOACs; inspiring partnership across the system.

Personalising evidence-based medicine to reduce polypharmacy

11 February 2025An insight on principles of patient centred structured medication reviews; using the current evidence and shared decision making to facilitate de-prescribing.

Personalised evidence-based medicine to minimise polypharmacy

4 March 2025A consultant pharmacist used case studies to illustrate a patient-centered approach to deprescribing in patients with problematic polypharmacy.

Managing complexities of medication use across care boundaries

26 June 2024Exploring the risks for patients on complex or specialist medicines moving across care boundaries with a focus on strategies to reduce harms